Literature DB >> 15328353

Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes.

John P Hobson1, Sarah Netzel-Arnett, Roman Szabo, Sophie M Réhault, Frank C Church, Dudley K Strickland, Daniel A Lawrence, Toni M Antalis, Thomas H Bugge.   

Abstract

We report the identification and functional analysis of a type II transmembrane serine protease encoded by the mouse differentially expressed in squamous cell carcinoma (DESC) 1 gene, and the definition of a cluster of seven homologous DESC1-like genes within a 0.5-Mb region of mouse chromosome 5E1. This locus is syntenic to a region of human chromosome 4q13.3 containing the human orthologues of four of the mouse DESC1-like genes. Bioinformatic analysis indicated that all seven DESC1-like genes encode functional proteases. Direct cDNA cloning showed that mouse DESC1 encodes a multidomain serine protease with an N-terminal signal anchor, a SEA (sea urchin sperm protein, enterokinase, and agrin) domain, and a C-terminal serine protease domain. The mouse DESC1 mRNA was present in epidermal, oral, and male reproductive tissues and directed the translation of a membrane-associated 60-kDa N-glycosylated protein with type II topology. Mouse DESC1 was synthesized in insect cells as a zymogen that could be activated by exposure to trypsin. The purified activated DESC1 hydrolyzed synthetic peptide substrates, showing a preference for Arg in the P1 position. DESC1 proteolytic activity was abolished by generic inhibitors of serine proteases but not by other classes of protease inhibitors. Most interestingly, DESC1 formed stable inhibitory complexes with both plasminogen activator inhibitor-1 and protein C inhibitor that are expressed in the same tissues with DESC1, suggesting that type II transmembrane serine proteases may be novel targets for serpin inhibition. Together, these data show that mouse DESC1 encodes a functional cell surface serine protease that may have important functions in the epidermis, oral, and reproductive epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328353     DOI: 10.1074/jbc.M403299200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

2.  Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.

Authors:  Yuushi Okumura; Masaki Hayama; Etsuhisa Takahashi; Mieko Fujiuchi; Aki Shimabukuro; Mihiro Yano; Hiroshi Kido
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

Review 3.  Type II transmembrane serine proteases.

Authors:  Thomas H Bugge; Toni M Antalis; Qingyu Wu
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

4.  Spink13, an epididymis-specific gene of the Kazal-type serine protease inhibitor (SPINK) family, is essential for the acrosomal integrity and male fertility.

Authors:  Li Ma; Heguo Yu; Zimei Ni; Shuanggang Hu; Wubin Ma; Chen Chu; Qiang Liu; Yonglian Zhang
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

Review 5.  Matriptase: potent proteolysis on the cell surface.

Authors:  Karin List; Thomas H Bugge; Roman Szabo
Journal:  Mol Med       Date:  2006 Jan-Mar       Impact factor: 6.354

6.  Iterative, multiplexed CRISPR-mediated gene editing for functional analysis of complex protease gene clusters.

Authors:  LuLu K Callies; Daniel Tadeo; Jan Simper; Thomas H Bugge; Roman Szabo
Journal:  J Biol Chem       Date:  2019-09-09       Impact factor: 5.157

7.  Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.

Authors:  Roman Szabo; Sarah Netzel-Arnett; John P Hobson; Toni M Antalis; Thomas H Bugge
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 8.  Membrane-anchored serine proteases in health and disease.

Authors:  Toni M Antalis; Thomas H Bugge; Qingyu Wu
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

9.  Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HAT.

Authors:  Katiuchia Uzzun Sales; John P Hobson; Rebecca Wagenaar-Miller; Roman Szabo; Amber L Rasmussen; Alexandra Bey; Maham F Shah; Alfredo A Molinolo; Thomas H Bugge
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

10.  Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase.

Authors:  Thomas A Prohaska; Felix C Wahlmüller; Margareta Furtmüller; Margarethe Geiger
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.